特發(fā)性膜性腎病與成人腎病綜合征的免疫抑制治療
《特發(fā)性膜性腎病與成人腎病綜合征的免疫抑制治療》內(nèi)容預(yù)覽
Background
Idiopathic membranous nephropathy (IMN) is the most common form of nephrotic syndrome in adults. The disease shows a benign or indolent course in the majority of patients, with a rate of spontaneous complete or partial remission of nephrotic syndrome as high as 30% or more. Despite this, 30-40% of patients progress toward end-stage renal failure (ESRF) within 5-15 years.
Objectives
To assess the benefits and harms of immunosuppressive treatment for IMN in adults. 、
Search strategy
We searched the Cochrane Renal Group Specialised Register (December 2003), The Cochrane Central Register of Controlled Trials (CENTRAL) (Cochrane Library Issue 4, 2003), MEDLINE, Pre-MEDLINE (1966 - December 2003), EMBASE (1980 - December 2003), reference lists of nephrology textbooks, review articles, prospective trial registers, relevant trials, abstracts from nephrology scientific meetings and the Internet without language restriction. We contacted principal investigators of controlled studies.
Selection criteria
Randomised controlled trials (RCTs) and quasi-RCTs comparing any immunosuppressive interventions for the treatment of IMN in adults.
Data collection and analysis
Two reviewers independently assessed and extracted information. Information was collected on method, participants, interventions and outcomes (death, ESRF, proteinuria, serum creatinine, GRF, remission, adverse events).
《特發(fā)性膜性腎病與成人腎病綜合征的免疫抑制治療》完整版下載地址：
http://ziyuan.iiyi.com/source/down/2310114.html
本站所注明來源為"愛愛醫(yī)"的文章，版權(quán)歸作者與本站共同所有，非經(jīng)授權(quán)不得轉(zhuǎn)載。
本站所有轉(zhuǎn)載文章系出于傳遞更多信息之目的，且明確注明來源和作者，不希望被轉(zhuǎn)載的媒體或個(gè)人可與我們
聯(lián)系z(mì)lzs@120.net，我們將立即進(jìn)行刪除處理
熱點(diǎn)圖文
-
急性腎功能衰竭時(shí)體內(nèi)代謝改變的特點(diǎn)是什么?
腎臟亦是參與機(jī)體代謝的器官之一,尤其是在水、電解質(zhì)與酸堿平衡的維持,代謝中...[詳細(xì)]
-
造影劑腎病的中國專家共識(shí)
造影劑腎病是碘造影劑應(yīng)用過程中的重要并發(fā)癥，也是醫(yī)源性腎功能衰竭的重要組成...[詳細(xì)]
